SUSPENSION OF TRADE. Notice from the Executive Cha
Post# of 4861
Dear shareholders, investors and interested parties.
Due to the complexity of the deal, which will soon be announced to the market, and its value impact on MCL and QBL, the Board of Queensland Bauxite Limited feel it is necessary to request a further extension from the ASX, until Thursday the 17th of May. The board will continue discussions and consult with the ASX, making sure that the Company is diligent, in its role, to satisfy all ASX listing requirements, and more importantly, guarantee that the ASX's approval of this significant acquisition, will be to the maximum benefit of the company and its shareholders.
We thank all our shareholders/investors for their patience and we will be working diligently to expedite this matter, with the utmost urgency, within this requested extension period.
Pnina Feldman
Executive Chairperson
QUEENSLAND BAUXITE LIMITED (ASX: QBL)
Here you have the possibility to take advantage on facts and info from QBL. Like the QBL on ASX website chapter, who can provide verified facts; here is regulated on-line stockbrokers suggestion, no games info and a good sum up. Voluntary suspension is requested regarding a significant and strategic acquisition by QBL’s subsidiary Medical Cannabis Limited until next week. Contact information to the QBL Investor service, who can reply on questions.
https://www.queenslandbauxite.com/